AGTC Applied Genetic Technologies Corp

Applied Genetic Technologies Corp is a clinical-stage biotechnology company focused on gene therapy through a nontoxic adeno-associated virus. The company also offers products such as promoters, expression cassettes, and capsids for gene therapy.

$0.75
As of 06/28/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/27/2014
Outstanding shares:  50,731,903
Average volume:  318,628
Market cap:   $31,301,584
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   -2.58
PB ratio:   0.67
PS ratio:   62.60
Return on equity:   -122.84%
Net income %:   -12,650.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy